The interactions between attention deficit hyperactivity syndrome and addictions

Abstract

In the article, a group of early career psychiatrists presents the results of a discussion about the relationship between attention deficit and hyperactivity disorder (ADHD) and addictions. Modern views on the commonality of the occurrence of these conditions at the genetic, morphological and functional levels are considered. Possible clinical manifestations and the frequency of comorbidity are described. Modern pharmacological and non-pharmacological approaches to the treatment of these comorbid conditions are discussed in detail separately. The features of therapy in the combination of ADHD with various addictions are highlighted.

Keywords

ADHD / addictions / comorbidity

References

[1] Barkley RA, Fischer M, Smallish L, et al. Young adult follow-up of hyperactive children: antisocial activities and drug use. Journal of Child Psychology and Psychiatry, and Allied Disciplines. 2004;45(2):195–211. doi: 10.1111/j.1469-7610.2004.00214.x

[2] Barkley R.A., Fischer M., Smallish L., et al. Young adult follow-up of hyperactive children: antisocial activities and drug use // Journal of Child Psychology and Psychiatry, and Allied Disciplines. 2004. Vol. 45, № 2. P. 195–211. doi: 10.1111/j.1469-7610.2004.00214.x

[3] Sibley MH, Pelham WE, Molina BSG, et al. The role of early childhood ADHD and subsequent CD in the initiation and escalation of adolescent cigarette, alcohol, and marijuana use. Journal of Abnormal Psychology. 2014;123(2):362–74. doi: 10.1037/a0036585

[4] Sibley M.H., Pelham W.E., Molina B.S.G., et al. The role of early childhood ADHD and subsequent CD in the initiation and escalation of adolescent cigarette, alcohol, and marijuana use // Journal of Abnormal Psychology. 2014. Vol. 123, № 2. P. 362–374. doi: 10.1037/a0036585

[5] Charach A, Yeung E, Climans T, et al. Childhood Attention-Deficit/Hyperactivity Disorder and Future Substance Use Disorders: Comparative Meta-Analyses. Journal of the American Academy of Child and Adolescent Psychiatry. 2011;50(1):9–21. doi: 10.1016/j.jaac.2010.09.019

[6] Charach A., Yeung E., Climans T., et al. Childhood Attention-Deficit/Hyperactivity Disorder and Future Substance Use Disorders: Comparative Meta-Analyses // Journal of the American Academy of Child and Adolescent Psychiatry. 2011. Vol. 50, № 1. P. 9–21. doi: 10.1016/j.jaac.2010.09.019

[7] van Emmerik-van Oortmerssen K, van de Glind G, van den Brink W et al. Prevalence of attention-deficit hyperactivity disorder in substance use disorder patients: A meta-analysis and meta-regression analysis. Drug and Alcohol Dependence. 2012;122(1-2):11–9. doi: 10.1016/j.drugalcdep.2011.12.007

[8] van Emmerik-van Oortmerssen K., van de Glind G., van den Brink W., et al. Prevalence of attention-deficit hyperactivity disorder in substance use disorder patients: A meta-analysis and meta-regression analysis // Drug and Alcohol Dependence. 2012. Vol. 122, № 1–2. P. 11–19. doi: 10.1016/j.drugalcdep.2011.12.007

[9] Evren C, Evren B, Bozkurt M, et al. Effects of lifetime tobacco, alcohol and drug use on psychological and behavioral problems among 10th grade students in Istanbul. International Journal of Adolescence Medicine and Health. 2015;27(4):405–13. doi: 10.1515/ijamh-2014-0040

[10] Evren C., Evren B., Bozkurt M., et al. Effects of lifetime tobacco, alcohol and drug use on psychological and behavioral problems among 10th grade students in Istanbul // International Journal of Adolescence Medicine and Health. 2015. Vol. 27, № 4. P. 405–413. doi: 10.1515/ijamh-2014-0040

[11] Darke S, De Genhardt L, Mattick R. Mortality Amongst Illicit Drug Users: Epidemiology, Causes, and Intervention. Cambridge: Cambridge University Press; 2006.

[12] Darke S., De Genhardt L., Mattick R. Mortality Amongst Illicit Drug Users: Epidemiology, Causes, and Intervention. Cambridge: Cambridge University Press; 2006.

[13] Slobodin O, Crunelle CL. Mini Review: Socio-Cultural Influences on the Link Between ADHD and SUD. Frontiers in Public Health. 2019;7:173. doi: 10.3389/fpubh.2019.00173

[14] Slobodin O., Crunelle C.L. Mini Review: Socio-Cultural Influences on the Link Between ADHD and SUD // Frontiers in Public Health. 2019. Vol. 7. P. 173. doi: 10.3389/fpubh.2019.00173

[15] Polanczyk G, de Lima M, Horta B, et al. The Worldwide Prevalence of ADHD: A Systematic Review and Metaregression Analysis. American Journal of Psychiatry. 2007;164(6):942–8. doi: 10.1176/ajp.2007.164.6.942

[16] Polanczyk G., de Lima M., Horta B., et al. The Worldwide Prevalence of ADHD: A Systematic Review and Metaregression Analysis // American Journal of Psychiatry. 2007. Vol. 164, № 6. P. 942–948. doi: 10.1176/ajp.2007.164.6.942

[17] Hayman V, Fernandez TV. Genetic Insights Into ADHD Biology. Frontiers in Psychiatry. 2018;9:251. doi: 10.3389/fpsyt.2018.00251

[18] Hayman V., Fernandez T.V. Genetic Insights Into ADHD Biology // Frontiers in Psychiatry. 2018. Vol. 9. P. 251. doi: 10.3389/fpsyt.2018.00251

[19] Robles R, de la Peña F, Medina-Mora M, et al. ICD-11 Guidelines for Mental and Behavioral Disorders of Children and Adolescents: Reliability and Clinical Utility. Psychiatric Services. 2021:appi.ps.2020008. doi: 10.1176/appi.ps.202000830

[20] Robles R., de la Peña F., Medina-Mora M., et al. ICD-11 Guidelines for Mental and Behavioral Disorders of Children and Adolescents: Reliability and Clinical Utility // Psychiatric Services. 2021. appi.ps.2020008. doi: 10.1176/appi.ps.202000830

[21] Perugi G, Pallucchini A, Rizzato S, et al. Pharmacotherapeutic strategies for the treatment of attention-deficit hyperactivity (ADHD) disorder with comorbid substance-use disorder (SUD). Expert Opinion of Pharmacotherapy. 2018;20(3):343–55. doi: 10.1080/14656566.2018.1551878

[22] Perugi G., Pallucchini A., Rizzato S., et al. Pharmacotherapeutic strategies for the treatment of attention-deficit hyperactivity (ADHD) disorder with comorbid substance-use disorder (SUD) // Expert Opinion of Pharmacotherapy. 2018. Vol. 20, № 3. P. 343–355. doi: 10.1080/14656566.2018.1551878

[23] Posner J, Polanczyk G, Sonuga-Barke E. Attention-deficit hyperactivity disorder. The Lancet. 2020;395(10222):450–62. doi: 10.1016/s0140-6736(19)33004-1

[24] Posner J., Polanczyk G., Sonuga-Barke E. Attention-deficit hyperactivity disorder // The Lancet. 2020. Vol. 395, № 10222. P. 450–462. doi: 10.1016/s0140-6736(19)33004-1

[25] Yadav SK, Bhat AA, Hashem S, et al. Genetic variations influence brain changes in patients with attention-deficit hyperactivity disorder. Translational Psychiatry. 2021;11(1):349. doi: 10.1038/s41398-021-01473-w

[26] Yadav S.K., Bhat A.A., Hashem S., et al. Genetic variations influence brain changes in patients with attention-deficit hyperactivity disorder // Translational Psychiatry. 2021. Vol. 11, № 1. P. 349. doi: 10.1038/s41398-021-01473-w

[27] Wimberley T, Agerbo E, Horsdal H, et al. Genetic liability to ADHD and substance use disorders in individuals with ADHD. Addiction. 2020;115(7):1368–77. doi: 10.1111/add.14910

[28] Wimberley T., Agerbo E., Horsdal H., et al. Genetic liability to ADHD and substance use disorders in individuals with ADHD // Addiction. 2020. Vol. 115, № 7. P. 1368–1377. doi: 10.1111/add.14910

[29] Mathews C, Morrell H, Molle J. Video game addiction, ADHD symptomatology, and video game reinforcement. The American Journal of Drug and Alcohol Abuse. 2018;45(1):67–76. doi: 10.1080/00952990.2018.1472269

[30] Mathews C., Morrell H., Molle J. Video game addiction, ADHD symptomatology, and video game reinforcement // The American Journal of Drug and Alcohol Abuse. 2018. Vol. 45, № 1. P. 67–76. doi: 10.1080/00952990.2018.1472269

[31] Menendez-García A, Jiménez-Arroyo A, Rodrigo-Yanguas M, et al. Internet, video game and mobile phone addiction in children and adolescents: a case-control study. Adicciones. 2020;20(10). doi: 10.20882/adicciones.1469

[32] Menendez-García A., Jiménez-Arroyo A., Rodrigo-Yanguas M., et al. Internet, video game and mobile phone addiction in children and adolescents: a case-control study // Adicciones. 2020. Vol. 20, № 10. doi: 10.20882/adicciones.1469

[33] Samela T, Innamorati M, Lester D, et al. The association between adult ADHD and food addiction: A mediation analysis. Appetite. 2021;167:105613. doi: 10.1016/j.appet.2021.105613

[34] Samela T., Innamorati M., Lester D., et al. The association between adult ADHD and food addiction: A mediation analysis // Appetite. 2021. Vol. 167. P. 105613. doi: 10.1016/j.appet.2021.105613

[35] Spera V, Pallucchini A, Maiello M, et al. Substance Use Disorder in Adult-Attention Deficit Hyperactive Disorder Patients: Patterns of Use and Related Clinical Features. International Journal of Environmental Research and Public Health. 2020;17(10):3509. doi: 10.3390/ijerph17103509

[36] Spera V., Pallucchini A., Maiello M., et al. Substance Use Disorder in Adult-Attention Deficit Hyperactive Disorder Patients: Patterns of Use and Related Clinical Features // International Journal of Environmental Research and Public Health. 2020. Vol. 17, № 10. P. 3509. doi: 10.3390/ijerph17103509

[37] Soler Artigas M, Sánchez-Mora C, Rovira P, et al. Attention-deficit/hyperactivity disorder and lifetime cannabis use: genetic overlap and causality. Molecular Psychiatry. 2019;25(10):2493–503. doi: 10.1038/s41380-018-0339-3

[38] Soler Artigas M., Sánchez-Mora C., Rovira P., et al. Attention-deficit/hyperactivity disorder and lifetime cannabis use: genetic overlap and causality // Molecular Psychiatry. 2019. Vol. 25, № 10. P. 2493–2503. doi: 10.1038/s41380-018-0339-3

[39] Young S, Woodhouse E. Assessment and treatment of substance use in adults with ADHD: a psychological approach. Journal of Neural Transmission. 2021;128(7):1099–108. doi: 10.1007/s00702-020-02277-w

[40] Young S., Woodhouse E. Assessment and treatment of substance use in adults with ADHD: a psychological approach // Journal of Neural Transmission. 2021. Vol. 128, № 7. P. 1099–1108. doi: 10.1007/s00702-020-02277-w

[41] Kooij SJJ, Bejerot S, Blackwell A, et al. European consensus statement on diagnosis and treatment of adult ADHD: The European Network Adult ADHD. BMC Psychiatry. 2010;10:67. doi: 10.1186/1471-244x-10-67

[42] Kooij S.J.J., Bejerot S., Blackwell A., et al. European consensus statement on diagnosis and treatment of adult ADHD: The European Network Adult ADHD // BMC Psychiatry. 2010. Vol. 10. P. 67. doi: 10.1186/1471-244x-10-67

[43] Pozzi M, Bertella S, Gatti E, et al. Emerging drugs for the treatment of attention-deficit hyperactivity disorder (ADHD). Expert Opinion on Emerging Drugs. 2020;25(4):395–407. doi: 10.1080/14728214.2020.1820481

[44] Pozzi M., Bertella S., Gatti E., et al. Emerging drugs for the treatment of attention-deficit hyperactivity disorder (ADHD) // Expert Opinion on Emerging Drugs. 2020. Vol. 25, № 4. P. 395–407. doi: 10.1080/14728214.2020.1820481

[45] Wong HC, Zaman R. Neurostimulation in Treating ADHD. Psychiatria Danubina. 2019;31(Suppl 3):265–75.

[46] Wong H.C., Zaman R. Neurostimulation in Treating ADHD // Psychiatria Danubina. 2019. Vol. 31, Suppl. 3. P. 265–275.

[47] Arns M, Clark CR, Trullinger M, et al. Neurofeedback and Attention-Deficit/Hyperactivity-Disorder (ADHD) in Children: Rating the Evidence and Proposed Guidelines. Applied Psychophysiology and Biofeedback. 2020;45(2):39–48. doi: 10.1007/s10484-020-09455-2

[48] Arns M., Clark C.R., Trullinger M., et al. Neurofeedback and Attention-Deficit/Hyperactivity-Disorder (ADHD) in Children: Rating the Evidence and Proposed Guidelines // Applied Psychophysiology and Biofeedback. 2020. Vol. 45, № 2. P. 39–48. doi: 10.1007/s10484-020-09455-2

[49] Lim CG, Lim-Ashworth NSJ, Fung DSS. Updates in technology-based interventions for attention deficit hyperactivity disorder. Current Opinion in Psychiatry. 2020;33(6):577–85. doi: 10.1097/YCO.0000000000000643

[50] Lim C.G., Lim-Ashworth N.S.J., Fung D.S.S. Updates in technology-based interventions for attention deficit hyperactivity disorder // Current Opinion in Psychiatry. 2020. Vol. 33, № 6. P. 577–585. doi: 10.1097/YCO.0000000000000643

[51] Gabriely R, Tarrasch R, Velicki M, et al. The influence of mindfulness meditation on inattention and physiological markers of stress on students with learning disabilities and/or attention deficit hyperactivity disorder. Research in Developmental Disability. 2020;100:103630. doi: 10.1016/j.ridd.2020.103630

[52] Gabriely R., Tarrasch R., Velicki M., et al. The influence of mindfulness meditation on inattention and physiological markers of stress on students with learning disabilities and/or attention deficit hyperactivity disorder // Research in Developmental Disability. 2020. Vol. 100. P. 103630. doi: 10.1016/j.ridd.2020.103630

[53] Chen SC, Yu BY, Suen LK, et al. Massage therapy for the treatment of attention deficit/hyperactivity disorder (ADHD) in children and adolescents: A systematic review and meta-analysis. Complementary Therapies in Medicine. 2019;42:389–99. doi: 10.1016/j.ctim.2018.12.011

[54] Chen S.C., Yu B.Y., Suen L.K., et al. Massage therapy for the treatment of attention deficit/hyperactivity disorder (ADHD) in children and adolescents: A systematic review and meta-analysis // Complementary Therapies in Medicine. 2019. Vol. 42. P. 389–399. doi: 10.1016/j.ctim.2018.12.011

[55] Păsărelu CR, Andersson G, Dobrean A. Attention-deficit/ hyperactivity disorder mobile apps: A systematic review. International Journal of Medical Informatics. 2020;138:104133. doi: 10.1016/j.ijmedinf.2020.104133

[56] Păsărelu C.R., Andersson G., Dobrean A. Attention-deficit/hyperactivity disorder mobile apps: A systematic review // International Journal of Medical Informatics. 2020. Vol. 138. P. 104133. doi: 10.1016/j.ijmedinf.2020.104133